ADA2 deficiency due to a novel structural variation in 22q11.1

Clin Genet. 2019 Jun;95(6):732-733. doi: 10.1111/cge.13518. Epub 2019 Mar 28.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abnormalities, Multiple*
  • Adenosine Deaminase / blood
  • Adenosine Deaminase / deficiency*
  • Adenosine Deaminase / genetics
  • Adenosine Deaminase / metabolism
  • Agammaglobulinemia / enzymology
  • Agammaglobulinemia / genetics*
  • Agammaglobulinemia / physiopathology
  • Chromosome Duplication*
  • Chromosomes, Human, Pair 22
  • DiGeorge Syndrome*
  • Frameshift Mutation
  • Humans
  • Intercellular Signaling Peptides and Proteins / blood
  • Intercellular Signaling Peptides and Proteins / deficiency*
  • Intercellular Signaling Peptides and Proteins / genetics*
  • Intercellular Signaling Peptides and Proteins / metabolism
  • Severe Combined Immunodeficiency / enzymology
  • Severe Combined Immunodeficiency / genetics*
  • Severe Combined Immunodeficiency / physiopathology
  • Whole Genome Sequencing

Substances

  • Intercellular Signaling Peptides and Proteins
  • ADA2 protein, human
  • Adenosine Deaminase

Supplementary concepts

  • Chromosome 22q11.2 Microduplication Syndrome
  • Severe combined immunodeficiency due to adenosine deaminase deficiency